Cargando…

CUSUMIN: A cumulative sum interval design for cancer phase I dose finding studies

Recently, model‐assisted designs, including the Bayesian optimal interval (BOIN) design with optimal thresholds to determine the dose for the next cohort, have been proposed for cancer phase I studies. Model‐assisted designs are useful because of their good performance as model‐based designs in addi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hatayama, Tomoyoshi, Yasui, Seiichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Main Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796866/ https://www.ncbi.nlm.nih.gov/pubmed/35833753 http://dx.doi.org/10.1002/pst.2247

Ejemplares similares

SCI: A Bayesian adaptive phase I/II dose‐finding design accounting for semi‐competing risks outcomes for immunotherapy trials
por: Zhang, Yifei, et al.
Publicado: (2022)

Escalation strategies for combination therapy Phase I trials
por: Sweeting, Michael J, et al.
Publicado: (2012)

A confidence function‐based posterior probability design for phase II cancer trials
por: Shan, Minghua
Publicado: (2020)

Dose‐escalation strategies which use subgroup information
por: Cotterill, Amy, et al.
Publicado: (2018)

An optimal stratified Simon two‐stage design
por: Parashar, Deepak, et al.
Publicado: (2016)

Bayesian central statistical monitoring using finite mixture models in multicenter clinical trials
por: Hatayama, Tomoyoshi, et al.
Publicado: (2020)

Practical and robust test for comparing binomial proportions in the randomized phase II setting
por: Attwood, Kristopher, et al.
Publicado: (2021)

Data-driven treatment selection for seamless phase II/III trials incorporating early-outcome data
por: Kunz, Cornelia Ursula, et al.
Publicado: (2014)

Delayed treatment effects, treatment switching and heterogeneous patient populations: How to design and analyze RCTs in oncology
por: Ristl, Robin, et al.
Publicado: (2020)

Response‐adaptive designs for binary responses: How to offer patient benefit while being robust to time trends?
por: Villar, Sofía S., et al.
Publicado: (2017)

Magnetic resonance imaging findings in patients with idiopathic olfactory dysfunction and normal findings on nasoendoscopy
por: Tung, I M, et al.
Publicado: (2023)

A novel equivalence probability weighted power prior for using historical control data in an adaptive clinical trial design: A comparison to standard methods
por: Bennett, Maxine, et al.
Publicado: (2021)

A compassionate imagery intervention for patients with persecutory delusions
por: Forkert, Ava, et al.
Publicado: (2022)

Cognitive appraisals of dissociation in psychosis: a new brief measure
por: Černis, Emma, et al.
Publicado: (2021)

Are young people with primary social anxiety disorder less likely to recover following generic CBT compared to young people with other primary anxiety disorders? A systematic review and meta-analysis
por: Evans, Rachel, et al.
Publicado: (2021)

Understanding agoraphobic avoidance: the development of the Oxford Cognitions and Defences Questionnaire (O-CDQ)
por: Rosebrock, Laina, et al.
Publicado: (2022)

Learning Curve and Complications of Unilateral Biportal Endoscopy: Cumulative Sum and Risk-Adjusted Cumulative Sum Analysis
por: Xu, Jinchao, et al.
Publicado: (2022)

THE PARADOXICAL TEXT `ON THE HEART', Part I
por: Lonie, I. M.
Publicado: (1973)

Reliability of algebraic sum to evaluate adjuvant pelvic radiotherapy and vaginal cuff brachytherapy cumulative doses in uterine cancers
por: Casale, Michelina, et al.
Publicado: (2022)

Resumption of professional football during the COVID-19 pandemic. Study findings from Iran
por: Hassanmirzaei, Bahar, et al.
Publicado: (2021)

Cumulative sum tests: theory and practice
por: Van Dobben de Bruyn, C S
Publicado: (1968)

60 years of Cimicifuga racemosa medicinal products: Clinical research milestones, current study findings and current development
por: Henneicke-von Zepelin, Hans-Heinrich
Publicado: (2017)

Treatment options in myocarditis and inflammatory cardiomyopathy: Focus on i. v. immunoglobulins
por: Maisch, B., et al.
Publicado: (2018)

Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies
por: Austin, Peter C
Publicado: (2011)

A review and re-interpretation of a group-sequential approach to sample size re-estimation in two-stage trials
por: Bowden, J, et al.
Publicado: (2014)

Do single‐arm trials have a role in drug development plans incorporating randomised trials?
por: Grayling, Michael J., et al.
Publicado: (2015)

Optimal composite scores for longitudinal clinical trials under the linear mixed effects model
por: Ard, M. Colin, et al.
Publicado: (2015)

Why are two mistakes not worse than one? A proposal for controlling the expected number of false claims
por: Jaki, Thomas, et al.
Publicado: (2016)

A proposal for a new PhD level curriculum on quantitative methods for drug development
por: Jaki, T., et al.
Publicado: (2018)

Blinded continuous monitoring in clinical trials with recurrent event endpoints
por: Friede, Tim, et al.
Publicado: (2018)

On estimands and the analysis of adverse events in the presence of varying follow‐up times within the benefit assessment of therapies
por: Unkel, Steffen, et al.
Publicado: (2018)

Α Markov model for longitudinal studies with incomplete dichotomous outcomes
por: Efthimiou, Orestis, et al.
Publicado: (2016)

Misspecification of at‐risk periods and distributional assumptions in estimating COPD exacerbation rates: The resultant bias in treatment effect estimation
por: Law, M., et al.
Publicado: (2016)

Reference‐based sensitivity analysis for time‐to‐event data
por: Atkinson, Andrew, et al.
Publicado: (2019)

Empirical evaluation of the implementation of the EMA guideline on missing data in confirmatory clinical trials: Specification of mixed models for longitudinal data in study protocols
por: Häckl, Sebastian, et al.
Publicado: (2019)

A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerations
por: Huber, Cynthia, et al.
Publicado: (2019)

Prior distributions for variance parameters in a sparse‐event meta‐analysis of a few small trials
por: Pateras, Konstantinos, et al.
Publicado: (2020)

Imputation of missing covariate in randomized controlled trials with a continuous outcome: Scoping review and new results
por: Kayembe, Mutamba T., et al.
Publicado: (2020)

Potential impact of COVID‐19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA‐TICS study
por: Lasch, Florian, et al.
Publicado: (2021)

A robust permutation test for the concordance correlation coefficient
por: Hutson, Alan D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9oq9bgpv1pamshf2dakcmp1b78